These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3562 related articles for article (PubMed ID: 25137507)
1. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507 [TBL] [Abstract][Full Text] [Related]
2. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome. Verit FF Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438 [TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study. Singh S; Akhtar N; Ahmad J Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of hs-CRP and visseral adiposity index in patients with policystic ovary syndrome by clinical and laboratory findings. Ün B; Dolapçıoğlu KS; Güler Okyay A; Şahin H; Beyazıt A Eur J Obstet Gynecol Reprod Biol; 2016 Sep; 204():16-20. PubMed ID: 27479317 [TBL] [Abstract][Full Text] [Related]
5. Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance. Bahceci M; Tuzcu A; Canoruc N; Tuzun Y; Kidir V; Aslan C Horm Res; 2004; 62(6):283-7. PubMed ID: 15542929 [TBL] [Abstract][Full Text] [Related]
6. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome. Alemzadeh R; Kichler J; Calhoun M Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657 [TBL] [Abstract][Full Text] [Related]
7. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome. Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421 [TBL] [Abstract][Full Text] [Related]
8. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations. Koo YA; Shin SY; Yoon BK; Choi D Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414 [TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [TBL] [Abstract][Full Text] [Related]
10. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Li X; Lin JF Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817 [TBL] [Abstract][Full Text] [Related]
11. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome. Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738 [TBL] [Abstract][Full Text] [Related]
12. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome. Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663 [TBL] [Abstract][Full Text] [Related]
13. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. Yildiz BO; Yarali H; Oguz H; Bayraktar M J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950 [TBL] [Abstract][Full Text] [Related]
14. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Pehlivanov B; Mitkov M Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711 [TBL] [Abstract][Full Text] [Related]
15. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome. Bahceci M; Aydemir M; Tuzcu A Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944 [TBL] [Abstract][Full Text] [Related]
16. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276 [TBL] [Abstract][Full Text] [Related]
17. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome. Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948 [TBL] [Abstract][Full Text] [Related]
18. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fenkci V; Fenkci S; Yilmazer M; Serteser M Fertil Steril; 2003 Jul; 80(1):123-7. PubMed ID: 12849813 [TBL] [Abstract][Full Text] [Related]
19. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. Sepilian V; Nagamani M J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109 [TBL] [Abstract][Full Text] [Related]
20. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Ardawi MS; Rouzi AA Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]